Market Overview

UPDATE: Morgan Stanley Reiterates On McKesson Following Investor Day

Share:
Related MCK
Billionaire-Tracking ETF Just Bulked Up On Health Care
Benzinga's M&A Chatter for Wednesday May 20, 2015
InsiderInsights.com Daily Round Up 5/28/15: BID, AVID, JGW, SNBC (Seeking Alpha)

In a report published Thursday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on McKesson (NYSE: MCK), and raised the price target from $197.00 to $205.00.

In the report, Morgan Stanley noted, “Investor day showcased MCK's mkt leadership, favorable ind trends and mgmt breadth. Incr margin targets highlight expansion levers, complemented by cap deployment. W/ strong generic inflation, Celesio & PSS synergies, and generic scale oppty, we view MCK as best positioned in group. PT to $205.”

McKesson closed on Wednesday at $187.35.

Latest Ratings for MCK

DateFirmActionFromTo
May 2015BairdMaintainsOutperform
May 2015BarclaysMaintainsOverweight
Mar 2015Deutsche BankMaintainsBuy

View More Analyst Ratings for MCK
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Price Target Analyst Ratings

 

Related Articles (MCK)

Around the Web, We're Loving...

Get Benzinga's Newsletters